
Jennifer Sue Pitrak Mcdonald
Examiner (ID: 18643, Phone: (571)270-3061 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1609, 3796, 3792, 1635, 1674 |
| Total Applications | 600 |
| Issued Applications | 220 |
| Pending Applications | 26 |
| Abandoned Applications | 355 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5777337
[patent_doc_number] => 20060105977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Desmoglein 4 is a novel gene involved in hair growth'
[patent_app_type] => utility
[patent_app_number] => 11/251340
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 25231
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105977.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251340
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251340 | Desmoglein 4 is a novel gene involved in hair growth | Oct 13, 2005 | Abandoned |
Array
(
[id] => 5638052
[patent_doc_number] => 20060069026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Treatment of obesity'
[patent_app_type] => utility
[patent_app_number] => 11/235232
[patent_app_country] => US
[patent_app_date] => 2005-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6266
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069026.pdf
[firstpage_image] =>[orig_patent_app_number] => 11235232
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/235232 | Treatment of obesity | Sep 26, 2005 | Abandoned |
Array
(
[id] => 5029132
[patent_doc_number] => 20070270579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 11/234730
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 93035
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270579.pdf
[firstpage_image] =>[orig_patent_app_number] => 11234730
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/234730 | RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) | Sep 22, 2005 | Abandoned |
Array
(
[id] => 5720730
[patent_doc_number] => 20060073505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Oligomeric compounds effecting drosha-mediated cleavage'
[patent_app_type] => utility
[patent_app_number] => 11/230992
[patent_app_country] => US
[patent_app_date] => 2005-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 29993
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073505.pdf
[firstpage_image] =>[orig_patent_app_number] => 11230992
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/230992 | Oligomeric compounds effecting drosha-mediated cleavage | Sep 19, 2005 | Abandoned |
Array
(
[id] => 5210964
[patent_doc_number] => 20070249548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Nucleoside Analog or Salts of the Same'
[patent_app_type] => utility
[patent_app_number] => 11/663086
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15964
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249548.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663086
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663086 | Nucleoside Analog or Salts of the Same | Sep 15, 2005 | Abandoned |
Array
(
[id] => 4753181
[patent_doc_number] => 20080161256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => utility
[patent_app_number] => 11/205646
[patent_app_country] => US
[patent_app_date] => 2005-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 96250
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161256.pdf
[firstpage_image] =>[orig_patent_app_number] => 11205646
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/205646 | RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) | Aug 16, 2005 | Abandoned |
Array
(
[id] => 7251208
[patent_doc_number] => 20050272817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Dermatological use and a dermatological preparation'
[patent_app_type] => utility
[patent_app_number] => 11/198133
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3017
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272817.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198133
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198133 | Dermatological use and a dermatological preparation | Aug 7, 2005 | Abandoned |
Array
(
[id] => 5720353
[patent_doc_number] => 20060073127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules'
[patent_app_type] => utility
[patent_app_number] => 11/179792
[patent_app_country] => US
[patent_app_date] => 2005-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20944
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 67
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073127.pdf
[firstpage_image] =>[orig_patent_app_number] => 11179792
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/179792 | Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules | Jul 10, 2005 | Issued |
Array
(
[id] => 6931731
[patent_doc_number] => 20050282766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers'
[patent_app_type] => utility
[patent_app_number] => 11/177138
[patent_app_country] => US
[patent_app_date] => 2005-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16134
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282766.pdf
[firstpage_image] =>[orig_patent_app_number] => 11177138
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/177138 | Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers | Jul 7, 2005 | Abandoned |
Array
(
[id] => 5446966
[patent_doc_number] => 20090048192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation'
[patent_app_type] => utility
[patent_app_number] => 11/569955
[patent_app_country] => US
[patent_app_date] => 2005-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43724
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048192.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569955
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569955 | Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation | Jun 1, 2005 | Abandoned |
Array
(
[id] => 4899813
[patent_doc_number] => 20080119427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation'
[patent_app_type] => utility
[patent_app_number] => 11/569931
[patent_app_country] => US
[patent_app_date] => 2005-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 45608
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20080119427.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569931
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569931 | Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation | Jun 1, 2005 | Abandoned |
Array
(
[id] => 5808322
[patent_doc_number] => 20060094677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Inhibition of apoptosis-specific eIF-5A (\"eIF-5A1\") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/134445
[patent_app_country] => US
[patent_app_date] => 2005-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 131
[patent_figures_cnt] => 131
[patent_no_of_words] => 35753
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094677.pdf
[firstpage_image] =>[orig_patent_app_number] => 11134445
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/134445 | Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics | May 22, 2005 | Abandoned |
Array
(
[id] => 5808322
[patent_doc_number] => 20060094677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Inhibition of apoptosis-specific eIF-5A (\"eIF-5A1\") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/134445
[patent_app_country] => US
[patent_app_date] => 2005-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 131
[patent_figures_cnt] => 131
[patent_no_of_words] => 35753
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094677.pdf
[firstpage_image] =>[orig_patent_app_number] => 11134445
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/134445 | Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics | May 22, 2005 | Abandoned |
Array
(
[id] => 7178892
[patent_doc_number] => 20050204414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Methods of blocking tissue destruction by autoreactive T cells'
[patent_app_type] => utility
[patent_app_number] => 11/128496
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12087
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20050204414.pdf
[firstpage_image] =>[orig_patent_app_number] => 11128496
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/128496 | Methods of blocking tissue destruction by autoreactive T cells | May 12, 2005 | Abandoned |
Array
(
[id] => 4515401
[patent_doc_number] => 07932234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-26
[patent_title] => 'Bispecific oligonucleotide for the treatment of CNS malignancies'
[patent_app_type] => utility
[patent_app_number] => 10/908496
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3599
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/932/07932234.pdf
[firstpage_image] =>[orig_patent_app_number] => 10908496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/908496 | Bispecific oligonucleotide for the treatment of CNS malignancies | May 12, 2005 | Issued |
Array
(
[id] => 7178889
[patent_doc_number] => 20050204413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Methods of blocking tissue destruction by autoreactive T cells'
[patent_app_type] => utility
[patent_app_number] => 11/128495
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12087
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20050204413.pdf
[firstpage_image] =>[orig_patent_app_number] => 11128495
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/128495 | Methods of blocking tissue destruction by autoreactive T cells | May 12, 2005 | Abandoned |
Array
(
[id] => 4976848
[patent_doc_number] => 20070218079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'METHOD TO INDUCE RNAI IN PROKARYOTIC ORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 11/596176
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5017
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218079.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596176
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596176 | METHOD TO INDUCE RNAI IN PROKARYOTIC ORGANISMS | May 11, 2005 | Abandoned |
Array
(
[id] => 5733487
[patent_doc_number] => 20060258604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Compositions and methods for the treatment of inflammatory bowel disease utilizing NF-kappaB decoy polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/125919
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 20653
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258604.pdf
[firstpage_image] =>[orig_patent_app_number] => 11125919
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/125919 | Compositions and methods for the treatment of inflammatory bowel disease utilizing NF-kappaB decoy polynucleotides | May 9, 2005 | Abandoned |
Array
(
[id] => 4807464
[patent_doc_number] => 20080171042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Cd44 Variants As Therapeutic Targets'
[patent_app_type] => utility
[patent_app_number] => 11/579785
[patent_app_country] => US
[patent_app_date] => 2005-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 18074
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171042.pdf
[firstpage_image] =>[orig_patent_app_number] => 11579785
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/579785 | Cd44 Variants As Therapeutic Targets | May 8, 2005 | Abandoned |
Array
(
[id] => 6977840
[patent_doc_number] => 20050287558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'SNPs of apolipoprotein B and modulation of their expression'
[patent_app_type] => utility
[patent_app_number] => 11/124020
[patent_app_country] => US
[patent_app_date] => 2005-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29340
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287558.pdf
[firstpage_image] =>[orig_patent_app_number] => 11124020
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/124020 | SNPs of apolipoprotein B and modulation of their expression | May 4, 2005 | Abandoned |